Understanding Preeclampsia: Cardiovascular Pathophysiology, Histopathological Insights and Molecular Biomarkers
Medical Sciences · 25.08.2025 · 13 (3) · 154
DOI: 10.3390/medsci13030154 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Sciences, online erschienen am 25.08.2025. Verfasst von Kaltrina Kutllovci Hasani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Medical University of Graz, 8036 Graz, Austria. Hauptthemen laut MEDLINE: Pre-Eclampsia, Biomarkers, Cardiovascular Diseases. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Preeclampsia (PE) is not merely a pregnancy complication but a clinical manifestation of underlying vascular dysfunction with long-term health implications. It is diagnosed after 20 weeks of gestation as new-onset hypertension with proteinuria or organ involvement. The condition arises from impaired placental development, particularly defective spiral artery remodeling, which leads to placental ischemia and the release of antiangiogenic factors such as soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin (sEng). These circulating factors contribute to systemic endothelial dysfunction, resulting in hypertension, inflammation, and multiorgan stress. Histopathological findings, including acute atherosis and abnormal vascular remodeling, further reflect the cardiovascular damage underlying PE. This review synthesizes emerging evidence on the vascular and histological mechanisms of PE, highlighting novel biomarkers such as microRNAs and neprilysin, and the potential of advanced diagnostic tools, including machine learning. Importantly, PE is now recognized not only as an obstetric disorder but also as an early marker of future cardiovascular disease. This paradigm shift emphasizes the need for personalized prevention strategies, close surveillance of high-risk women, and long-term cardiovascular follow-up. Pregnancy thus represents a critical window for early detection and intervention in women’s cardiovascular health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, Medical University of Graz, 8036 Graz, Austria.
- Department of Obstetrics and Gynaecology, Clinical Center Mother Theresa, 1000 Skopje, North Macedonia.
- Gravitational Physiology and Aging Research Unit, Division of Physiology and Pathophysiology, Otto Löwi Research Center of Vascular Biology, Immunity and Inflammation, Medical University of Graz, 8036 Graz, Austria.
- Centre for Space and Aviation Health, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai P.O. Box 505055, United Arab Emirates.
ORCID-Profile: Kaltrina Kutllovci Hasani, Nandu Goswami
Zitieren
APA
Kutllovci Hasani, K., Ajeti, N., & Goswami, N. (2025). Understanding Preeclampsia: Cardiovascular Pathophysiology, Histopathological Insights and Molecular Biomarkers. Medical Sciences, 13(3), 154. https://doi.org/10.3390/medsci13030154
Vancouver
Kutllovci Hasani K, Ajeti N, Goswami N. Understanding Preeclampsia: Cardiovascular Pathophysiology, Histopathological Insights and Molecular Biomarkers. Medical Sciences. 2025;13(3):154. doi:10.3390/medsci13030154
BibTeX
@article{KutllovciHasani2025,
author = {Kutllovci Hasani, Kaltrina and Ajeti, Nurxhan and Goswami, Nandu},
title = {Understanding Preeclampsia: Cardiovascular Pathophysiology, Histopathological Insights and Molecular Biomarkers},
journal = {Medical Sciences},
year = {2025},
volume = {13},
number = {3},
pages = {154},
doi = {10.3390/medsci13030154}
}
EUVIMED